| Symbol | PURR |
|---|---|
| Name | HYPERLIQUID STRATEGIES INC |
| Sector | UNDEFINED |
| Region | North America |
| Industry | Finance Services |
| Address | 100 OVERLOOK CENTER,SUITE 102, PRINCETON, New Jersey, 08540, United States |
| Telephone | +1 609 375-2227 |
| Fax | — |
| — | |
| Website | hypestrat.xyz |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0002078856 |
| Description | Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firms pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others. Additional info from NASDAQ: |
New Form 424B3 - Hyperliquid Strategies Inc <b>Filed:</b> 2026-08-27 <b>AccNo:</b> 0001193125-26-370737 <b>Size:</b> 2 MB
Read moreNew Form 424B3 - Hyperliquid Strategies Inc <b>Filed:</b> 2026-08-27 <b>AccNo:</b> 0001193125-26-370731 <b>Size:</b> 2 MB
Read moreHyperliquid Strategies Inc Reports Financial Results for the Fiscal Year Ended June 30, 2026
Read moreHyperliquid Strategies Inc Announces Webcast to Discuss Results for the Fiscal Year Ended June 30, 2026
Read moreNew Form SCHEDULE 13G/A - Hyperliquid Strategies Inc <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000919574-26-005258 <b>Size:</b> 10 KB
Read moreLEIBOWITZ LAWRENCE E 🟢 acquired 2.1K shares of Hyperliquid Strategies Inc (PURR) Transaction Date: Jul 01, 2026 | Filing ID: 296316
Read moreRosengren Eric S 🟢 acquired 4.8K shares of Hyperliquid Strategies Inc (PURR) Transaction Date: Jul 01, 2026 | Filing ID: 296314
Read moreKING THOMAS C. 🟢 acquired 4.8K shares of Hyperliquid Strategies Inc (PURR) Transaction Date: Jul 01, 2026 | Filing ID: 296313
Read moreBhatt Nailesh 🟢 acquired 1.6K shares of Hyperliquid Strategies Inc (PURR) Transaction Date: Jul 01, 2026 | Filing ID: 296312
Read moreHyperliquid Strategies Inc Added to the Russell 3000, Russell 2000 and S&P Global BMI Indices
Read more